Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ravenbhel Pharmaceuticals is a prominent Indian pharmaceutical company specializing in the development, manufacturing, and marketing of a wide range of therapeutic formulations. Established in 2000 and headquartered in Amritsar, the company operates state-of-the-art manufacturing facilities in Jammu that comply with WHO-GMP standards, with newer units designed for USFDA and UKMHRA compliance. Ravenbhel serves as a significant Contract Development and Manufacturing Organization (CDMO) for global leaders like Novartis and Abbott, while also maintaining a robust domestic presence in specialties such as orthopaedics, gynaecology, and paediatrics. Their extensive product portfolio includes tablets, capsules, oral liquids, and small-volume parenterals, supported by an integrated R&D center focused on formulation innovation and bioequivalence studies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ravenbhel Pharmaceuticals.